H. Lundbeck ASFRA:LDBA +3.13%81 FCF Margin % is 6.78% as of Mar. 2026, which is 62% below its 10-year median of 17.89. GuruFocus rates FRA:LDBA with a GF Score™ of 81/100 and a GF Value™ of €6.14 (Fairly Valued). The stock has 3 warning signs investors should review. Among 960 Drug Manufacturers companies, H. Lundbeck AS ranks better than 87.6% on this metric.
The historical rank and industry rank for H. Lundbeck AS's FCF Margin % or its related term are showing as below:
FRA:LDBA'
s FCF Margin % Range Over the Past 10 Years
Min: 10.18 Med: 17.89 Max: 29.52
Current: 18.91
During the past 13 years, the highest FCF Margin % of H. Lundbeck AS was 29.52%. The lowest was 10.18%. And the median was 17.89%.
FRA:LDBA's FCF Margin % is ranked better than 87.6% of 960
companies
in the Drug Manufacturers industry
Industry Median: 2.48
vs FRA:LDBA: 18.91
H. Lundbeck AS FCF Margin % Related Terms
H. Lundbeck AS FCF Margin % Historical Data
* Premium members only.
The historical data trend for H. Lundbeck AS's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:LDBA vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H. Lundbeck AS FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's FCF Margin % distribution charts can be found below:
* The bar in red indicates where H. Lundbeck AS's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H. Lundbeck AS (FRA:LDBA) has a FCF Margin % of 6.78% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on H. Lundbeck AS and its competitors. This is 62% below median its historical median of 17.89. Over the past decade, H. Lundbeck AS's FCF Margin % has ranged from 10.18 to 29.52. According to the industry distribution chart, H. Lundbeck AS ranks #119 out of 960 companies in the Drug Manufacturers industry, placing it in the top 12.4%.
Is H. Lundbeck AS's FCF Margin % too high?
H. Lundbeck AS's current FCF Margin % of 6.78% is 62% below median its 10-year median of 17.89. Over the past 10 years, this metric has ranged from a low of 10.18 to a high of 29.52. The Drug Manufacturers industry median FCF Margin % is 2.48. H. Lundbeck AS's value of 6.78% is 173.4% above this industry median. Based on the distribution chart, H. Lundbeck AS ranks #119 out of 960 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, H. Lundbeck AS has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does H. Lundbeck AS's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, H. Lundbeck AS ranks #119 out of 960 companies for FCF Margin %. This places H. Lundbeck AS in the top 12% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.48. H. Lundbeck AS's value of 6.78% is 173.4% above this benchmark. Historically, H. Lundbeck AS's own FCF Margin % has ranged from 10.18 to 29.52 over the past decade. While the company's 10-year median is 17.89 vs. the industry median of 2.48, H. Lundbeck AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H. Lundbeck AS's current FCF Margin % of 6.78% is 173.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on H. Lundbeck AS and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H. Lundbeck AS's current FCF Margin % is 6.78%, which is 62% below median its own 10-year median of 17.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H. Lundbeck AS stock overvalued right now?
Based on GuruFocus' analysis, H. Lundbeck AS (FRA:LDBA) is currently considered Fairly Valued. The stock's GF Value™ is €6.14, compared to a current price of €5.93 — trading 3.5% below its estimated fair value. The current FCF Margin % is 6.78%, which is 62% below median its 10-year median of 17.89 and 173.4% above the Drug Manufacturers industry median of 2.48. H. Lundbeck AS's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For H. Lundbeck AS (FRA:LDBA), the current FCF Margin % is 6.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H. Lundbeck AS (FRA:LDBA) Overvalued in 2026?
Based on GuruFocus' analysis, H. Lundbeck AS stock appears to be undervalued.
The current stock price of €5.93 is trading 3.5% below its estimated GF Value™ of €6.14.
GuruFocus considers H. Lundbeck AS to be Fairly Valued.
Key valuation signals for FRA:LDBA:
FCF Margin %: 6.78% (62% below median its 10-year median of 17.89)
GF Value™: €6.14 vs. price of €5.93 (3.5% below fair value)
Industry Position: 173.4% above the Drug Manufacturers median (#119 of 960)
No single metric tells the full story. See the FRA:LDBA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.
81GF Score
Get the complete analysis for FRA:LDBA
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LDBA has been successfully added to your 
